PLANTeDIT operates in the plant genome editing field to produce improved crop species through transformation technology and a CRISPR/Cas9 delivery system. It produces regulatory-free, consumer-oriented, DNA-free and sustainable genome edited crops and biopharmaceuticals. The company’s offering includes non-transgenic high oleic soya, which is produced by mutating the FAD2 gene, which eventually increases the oleic oil content in the soya bean. This product was developed through a collaboration between PLANTeDIT and ToolGen. The organization has also collaborated with RebelBio, University College Cork and IAPB. Headquartered in Cork, Ireland, PLANTeDIT is privately held.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.